Komal Joshi | IR |
Rich Murray | CEO & President |
Kim Drapkin | CFO |
Beth Trehu | CMO |
Boris Peaker | Cowen & Company |
Debjit Chattopadhyay | H.C. Wainwright |
Jim Birchenough | Wells Fargo |
Mike Ulz | Robert W. Baird |
Cory Kasimov | J.P. Morgan |
Good morning, ladies and gentlemen, and welcome to the Jounce Therapeutics First Quarter 2018 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time.
As a reminder, this conference is being recorded at the company's request. I will now turn the call over to your host, Komal Joshi, with Jounce Therapeutics.